Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Consumer,Galcanezumab,Chronic migraine prevention,Galcanezumab (Emgality),Options for investment,Community and Hospital,Nervous System
